TY - JOUR

T1 - Clinician treatment choices for post-traumatic stress disorder (PTSD) - Ambassadors survey of psychiatrists in 39 European countries

T2 - ambassadors survey of psychiatrists in 39 European countries

AU - Kuzman, Martina Rojnic

AU - Padberg, Frank

AU - Amann, Benedikt L.

AU - Schouler-Ocak, Meryam

AU - Bajic, Zarko

AU - Melartin, Tarja

AU - James, Adrian

AU - Beezhold, Julian

AU - Gómez, Jordi Artigue

AU - Arango, Celso

AU - Jendričko, Tihana

AU - Ismayilova, Jamila

AU - Flannery, William

AU - Чумаков, Егор Максимович

AU - Başar, Koray

AU - Vahip, Simavi

AU - Dudek, Dominika

AU - Samochowiec, Jerzy

AU - Mihajlović, Goran

AU - Rota, Fulvia

AU - Stoppe, Gabriela

AU - Dom, Geert

AU - Catthoor, Kirsten

AU - Chkonia, Eka

AU - Dos Santos, Maria João Heitor

AU - Telles, Diogo

AU - Falkai, Peter

AU - Courtet, Philippe

AU - Patarák, Michal

AU - Izakova, Lubomira

AU - Skugarevski, Oleg

AU - Barjaktarov, Stojan

AU - Babić, Dragan

AU - Račetović, Goran

AU - Fiorillo, Andrea

AU - Carpiniello, Bernardo

AU - Taube, Maris

AU - Melamed, Yuval

AU - Chihai, Jana

AU - Cozman, Doina Constanta Maria

AU - Mohr, Pavel

AU - Szekeres, György

AU - Delic, Mirjana

AU - Mazaliauskienė, Ramunė

AU - Tomcuk, Aleksandar

AU - Maruta, Nataliya

AU - Gorwood, Philip

PY - 2024/3/7

Y1 - 2024/3/7

N2 - BACKGROUND: Considering the recently growing number of potentially traumatic events in Europe, the European Psychiatric Association undertook a study to investigate clinicians' treatment choices for post-traumatic stress disorder (PTSD).METHODS: The case-based analysis included 611 participants, who correctly classified the vignette as a case of PTSD, from Central/ Eastern Europe (CEE) ( n = 279), Southern Europe (SE) ( n = 92), Northern Europe (NE) ( n = 92), and Western Europe (WE) ( N = 148). RESULTS: About 82% woulduse antidepressants (sertraline being the most preferred one). Benzodiazepines and antipsychotics were significantly more frequently recommended by participants from CEE (33 and 4%, respectively), compared to participants from NE (11 and 0%) and SE (9% and 3%). About 52% of clinicians recommended trauma-focused cognitive behavior therapy and 35% psychoeducation, irrespective of their origin. In the latent class analysis, we identified four distinct "profiles" of clinicians. In Class 1 ( N = 367), psychiatrists would less often recommend any antidepressants. In Class 2 ( N = 51), clinicians would recommend trazodone and prolonged exposure therapy. In Class 3 ( N = 65), they propose mirtazapine and eye movement desensitization reprocessing therapy. In Class 4 ( N = 128), clinicians propose different types of medications and cognitive processing therapy. About 50.1% of participants in each region stated they do not adhere to recognized treatment guidelines. CONCLUSIONS: Clinicians' decisions for PTSD are broadly similar among European psychiatrists, but regional differences suggest the need for more dialogue and education to harmonize practice across Europe and promote the use of guidelines.

AB - BACKGROUND: Considering the recently growing number of potentially traumatic events in Europe, the European Psychiatric Association undertook a study to investigate clinicians' treatment choices for post-traumatic stress disorder (PTSD).METHODS: The case-based analysis included 611 participants, who correctly classified the vignette as a case of PTSD, from Central/ Eastern Europe (CEE) ( n = 279), Southern Europe (SE) ( n = 92), Northern Europe (NE) ( n = 92), and Western Europe (WE) ( N = 148). RESULTS: About 82% woulduse antidepressants (sertraline being the most preferred one). Benzodiazepines and antipsychotics were significantly more frequently recommended by participants from CEE (33 and 4%, respectively), compared to participants from NE (11 and 0%) and SE (9% and 3%). About 52% of clinicians recommended trauma-focused cognitive behavior therapy and 35% psychoeducation, irrespective of their origin. In the latent class analysis, we identified four distinct "profiles" of clinicians. In Class 1 ( N = 367), psychiatrists would less often recommend any antidepressants. In Class 2 ( N = 51), clinicians would recommend trazodone and prolonged exposure therapy. In Class 3 ( N = 65), they propose mirtazapine and eye movement desensitization reprocessing therapy. In Class 4 ( N = 128), clinicians propose different types of medications and cognitive processing therapy. About 50.1% of participants in each region stated they do not adhere to recognized treatment guidelines. CONCLUSIONS: Clinicians' decisions for PTSD are broadly similar among European psychiatrists, but regional differences suggest the need for more dialogue and education to harmonize practice across Europe and promote the use of guidelines.

KW - Antidepressive Agents/therapeutic use

KW - Cognitive Behavioral Therapy

KW - Europe

KW - Humans

KW - Psychiatrists

KW - Stress Disorders, Post-Traumatic/drug therapy

UR - https://www.mendeley.com/catalogue/95383dd9-2b4e-33a1-9f81-4454c32a6d11/

U2 - 10.1192/j.eurpsy.2024.19

DO - 10.1192/j.eurpsy.2024.19

M3 - Review article

C2 - 38450651

VL - 67

JO - European Psychiatry

JF - European Psychiatry

SN - 0924-9338

IS - 1

M1 - e24

ER -